Keywords: زیگزاسیدون; Ziprasidone; Lipid-based drug delivery system; Poorly water-soluble drug; Silica-lipid hybrid microparticles; Food effect; Solubilisation; Oral delivery;
مقالات ISI زیگزاسیدون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زیگزاسیدون; Antipsychotic agents; Ziprasidone; Schizophrenia; Relapse; Treatment failure; Double-blind method;
Keywords: زیگزاسیدون; Aripiprazole; Behavioral sensitization; Cocaine; Counter-conditioning; Mice; Ziprasidone;
Keywords: زیگزاسیدون; Manic; Depressive; Adjunct; Adjunctive; Add-on; Combination; Long-term; Aripiprazole; Olanzapine; Quetiapine; Risperidone; Ziprasidone; Mood stabilizers; Lithium; Valproate; Valproic acid;
Keywords: زیگزاسیدون; Ziprasidone; Major depressive disorder; Anxious depression; Efficacy; Monotherapy;
Keywords: زیگزاسیدون; aripiprazole; olanzapine; quetiapine; risperidone; ziprasidone; second-generation antipsychotic; first generation antipsychotic; agitation
Keywords: زیگزاسیدون; Ziprasidone; Bipolar disease; Relapse prevention;
Keywords: زیگزاسیدون; Geodon; Ziprasidone; PTSD; Post-traumatic stress disorder
Ziprasidone, a second-generation antipsychotic drug, triggers a macrophage inflammatory response in vitro
Keywords: زیگزاسیدون; Ziprasidone; Antipsychotic drug; Inflammation; Allergen; Mononuclear cell; IL; interleukinl; Li; lithium; NO; nitric oxide; ROS; reactive oxygen molecules; TNFα; tumor necrosis factor alfa; PHA; phytohemagglutinin; SNP; single nucleotide polymorphism; Zi
An assessor-blinded, randomized comparison of efficacy and tolerability of switching from olanzapine to ziprasidone and the combination of both in schizophrenia spectrum disorders
Keywords: زیگزاسیدون; Ziprasidone; Olanzapine; Switching therapy; Combination therapy; Metabolic syndrome; Schizophrenia spectrum disorders;
Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro
Keywords: زیگزاسیدون; Lipid-based drug delivery systems; Self-nanoemulsifying drug delivery systems; Silica-lipid hybrid microparticles; Poorly water-soluble drugs; Ziprasidone; Antipsychotic; Food effect; Solubilization; Solid-dosage forms; Silica nanoparticles;
Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review
Keywords: زیگزاسیدون; CBZ; carbamazepine; DRESS; drug rash with eosinophilia and systemic symptoms; FDA; US Food and Drug Administration; IVIG; intravenous immunoglobulin; LTG; lamotrigine; PB; phenobarbital; PHT; phenytoin; SJS; Stevens-Johnson syndrome; VPA; valproate; ZIP;
Effects of ziprasidone, SCH23390 and SB277011 on spatial memory in the Morris water maze test in naive and MK-801 treated mice
Keywords: زیگزاسیدون; Ziprasidone; SCH23390; SB277011; Cognition; Morris water maze; MK-801; Mice
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone
Keywords: زیگزاسیدون; AUCinf; area under the serum concentration-time profile from time 0 extrapolated to infinite time; BA; bioavailability; Cmax; maximum serum concentration; Tmax; time for Cmax; SCT; swellable core technology; CCSD; coated crystals made by spray drying; IR;
A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
Keywords: زیگزاسیدون; Ziprasidone; Microextraction by packed sorbent (MEPS); HPLC; Plasma; Therapeutic drug monitoring (TDM);
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12Â weeks of treatment in first treated episode of psychosis
Keywords: زیگزاسیدون; Aripiprazole; Quetiapine; Ziprasidone; Weight gain; Prolactin; Leptin; Metabolic side effects; First-episode psychosis; Medication-naïve;
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial
Keywords: زیگزاسیدون; Olanzapine; Perphenazine; Quetiapine; Risperidone; Ziprasidone; Pharmacogenetics; Schizophrenia;
Treatment with Ziprasidone for schizophrenia patients with OCD
Keywords: زیگزاسیدون; Schizophrenia; OCD; Ziprasidone; Personalized medicine;
Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE Study
Keywords: زیگزاسیدون; Pharmacogenomics; CATIE trial; Olanzapine; Risperidone; Quetiapine; Ziprasidone;
Assessment of propofol, midazolam and ziprasidone, or the combinations for the prevention of acute cocaine toxicity in a mouse model
Keywords: زیگزاسیدون; Cocaine intoxication; Propofol; Midazolam; Ziprasidone; New generation antipsychotic
Intramuscular Ziprasidone: Influence of Alcohol and Benzodiazepines on Vital Signs in the Emergency Setting
Keywords: زیگزاسیدون; ziprasidone; agitation; acute agitation; alcohol intoxication; second-generation antipsychotic
Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells
Keywords: زیگزاسیدون; PTSD, post-traumatic stress disorder; ESPS, enhanced single prolonged stress; NSCs, neural stem cells; ZIP, ziprasidone; p-ERK1/2, phosphorylation extracellular regulated protein kinases; BrdU, bromodeoxyuridinePost-traumatic stress disorder; Ziprasidone;
Lessons learned in the conduct of a global, large simple trial of treatments indicated for schizophrenia
Keywords: زیگزاسیدون; Large simple trial; Schizophrenia; ZODIAC; Recruitment; Retention; Ziprasidone
Are Oral Medications Effective in the Management of Acute Agitation?
Keywords: زیگزاسیدون; risperidone; olanzapine; aripiprazole; ziprasidone; oral antipsychotic; atypical antipsychotic; second generation antipsychotic; neuroleptic; agitation
Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients
Keywords: زیگزاسیدون; schizophrenia; pharmacogenetics; olanzapine; perazine; ziprasidone
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: Long-term changes in weight and metabolic profiles
Keywords: زیگزاسیدون; Metabolic syndrome; Medical comorbidity; Treatment remission; Ziprasidone
Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: A review of data from prospective, randomised studies
Keywords: زیگزاسیدون; delirium; prevention; treatment; intensive care unit; critical care; critical illness; hospital; drug therapy; randomised controlled trial; haloperidol; ziprasidone; quetiapine; olanzapine; antipsychotic; dexmedetomidine
Open adjunctive ziprasidone associated with weight loss in obese and overweight bipolar disorder patients
Keywords: زیگزاسیدون; Bipolar disorder; Treatment; Depression; Weight loss; Ziprasidone;
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone
Keywords: زیگزاسیدون; Schizophrenia; Lurasidone; Ziprasidone; Antipsychotic; Neuropsychology;
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
Keywords: زیگزاسیدون; Lurasidone; SM-13496; Ziprasidone; Schizophrenia; Antipsychotic; Atypical;
Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: Analyses of ziprasidone clinical study data
Keywords: زیگزاسیدون; Remission; Schizophrenia; Prediction; Ziprasidone
Calculated carbon–hydrogen bond dissociation enthalpies for predicting oxidative susceptibility of drug substance molecules
Keywords: زیگزاسیدون; Computational stability; Bond dissociation energy (BDE); Quantum mechanics; Semi-empirical methods; AM1; SAM1; PM3; RM1; PM5; PM6; DFT (density functional theory); Sertraline; Ziprasidone; Trovafloxacin; Varenicline; Ezlopitant; Quinuclidines
Ziprasidone for Psychotic Disorders: A Meta-Analysis and Systematic Review of the Relationship Between Pharmacokinetics, Pharmacodynamics, and Clinical Profile
Keywords: زیگزاسیدون; antipsychotic; meta-analysis; pharmacokinetic; premature study discontinuation; psychosis; schizophrenia; tolerability; ziprasidone
Molecular Dynamics of the Cryomilled Base and Hydrochloride Ziprasidones by Means of Dielectric Spectroscopy
Keywords: زیگزاسیدون; Molecular Dynamics; milling; crystallization; dissolution rate; ziprasidone; dielectric spectroscopy;
Efficacy of ziprasidone in dysphoric mania: Pooled analysis of two double-blind studies
Keywords: زیگزاسیدون; Dysphoric mania; Dysphoria; Bipolar mania; Mixed mania; Ziprasidone;
Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice
Keywords: زیگزاسیدون; Dopamine D2 receptor; Atypical antipsychotic drugs; Olanzapine; Risperidone; Ziprasidone; Body weight gain; Schizophrenia
Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia
Keywords: زیگزاسیدون; Schizophrenia; Recent onset; Cognition; Randomized controlled trial; Ziprasidone; Olanzapine;
Electroanalytical characteristics of antipsychotic drug ziprasidone and its determination in pharmaceuticals and serum samples on solid electrodes
Keywords: زیگزاسیدون; Ziprasidone; Voltammetry; Boron-doped diamond electrode; Glassy carbon electrode; Pharmaceuticals
Ziprasidone monotherapy in bipolar II depression: An open trial
Keywords: زیگزاسیدون; Bipolar II; Major depression; Ziprasidone
Mortality in patients with dementia treateds with atypical antipsychotics (olanzapine, quetiapine, and ziprasidone)
Keywords: زیگزاسیدون; Atypical antipsychotic agents; Quetiapine; Olanzapine; Ziprasidone; Cardiovascular risk; Cognitive defect dementia; Mortality; Adverse drug reaction; Agentes antipsicóticos atÃpicos; Quetiapina; Olanzapina; Ziprasidona; Riesgo cardiovascular; Demencia;
Mortalidad en pacientes con demencia tratados con antipsicóticos atÃpicos (olanzapina, quetiapina y ziprasidona)
Keywords: زیگزاسیدون; Agentes antipsicóticos atÃpicos; Quetiapina; Olanzapina; Ziprasidona; Riesgo cardiovascular; Demencia; Mortalidad; Reacciones adversas a medicamentos; Atypical antipsychotic agents; Quetiapine; Olanzapine; Ziprasidone; Cardiovascular risk; Cognitive def
The use of ziprasidone in clinical practice: Analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey
Keywords: زیگزاسیدون; Ziprasidone; Therapeutic drug monitoring; Schizophrenia; Plasma concentration; Drug interactions
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder
Keywords: زیگزاسیدون; Bipolar disorder; Dose; Effectiveness; Schizophrenia; Ziprasidone;
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment
Keywords: زیگزاسیدون; Schizophrenia; Signal detection method; Olanzapine; Ziprasidone; Glucose intolerance; Dyslipidemia
Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model
Keywords: زیگزاسیدون; Atypical antipsychotics; Metabolic; Insulin resistance; Insulin secretion; Clozapine; Olanzapine; Ziprasidone; Haloperidol; Risperidone;
Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder
Keywords: زیگزاسیدون; Aripiprazole; Dosing; Olanzapine; Quetiapine; Risperidone; Ziprasidone;
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials
Keywords: زیگزاسیدون; All-cause discontinuation; Effectiveness; Schizophrenia; Randomized clinical trial; Ziprasidone
Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats
Keywords: زیگزاسیدون; Ziprasidone; Haloperidol; Brain-derived neurotrophic factor; Stress; Hippocampus; Neocortex
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
Keywords: زیگزاسیدون; Ziprasidone; Clozapine; Treatment resistance; Tolerability
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
Keywords: زیگزاسیدون; Ziprasidone; Clozapine; Treatment resistance; Tolerability